Stay updated on DMD Gene Therapy Safety Study Clinical Trial
Sign up to get notified when there's something new on the DMD Gene Therapy Safety Study Clinical Trial page.

Latest updates to the DMD Gene Therapy Safety Study Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a government operating-status notice and updated the version to v3.2.0; removed the previous v3.1.0 tag and related version note.SummaryDifference4%
- Check19 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page was updated to revision v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated to include new information about Delandistrogene Moxeparvovec gene therapy for Duchenne muscular dystrophy, along with relevant research citations. Additionally, the facility name and location details have been added, while some previous location-related terms and references to muscular dystrophy have been removed.SummaryDifference7%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to DMD Gene Therapy Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DMD Gene Therapy Safety Study Clinical Trial page.